Suppression of Alcohol Preference by Naltrexone in the Rhesus Macaque: A Critical Role of Genetic Variation at the μ-Opioid Receptor Gene Locus

Biological Psychiatry

Volumn 67, Issue 1, 2010, Pages 78-80

  Barr, Christina S ^a   Chen, Scott A ^a   Schwandt, Melanie L ^a   Lindell, Stephen G ^a   Sun, Hui ^a   Suomi, Stephen J ^b   Heilig, Markus ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Alcoholism; family history; naltrexone; opioids

Indexed keywords

ALCOHOL; ASPARTAME; MU OPIATE RECEPTOR; NALTREXONE;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE INTERACTION; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; MACACA; MALE; NONHUMAN; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY;

ALCOHOLISM; ANIMALS; ASPARTAME; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; FEMALE; FOOD PREFERENCES; MACACA MULATTA; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, OPIOID, MU; SWEETENING AGENTS;

EID: 71349086194     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.07.026     Document Type: Article

References (20)

1. Volpicelli J.R., Alterman A.I., Hayashida M., and O'Brien C.P. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49 (1992) 876-880
2. O'Malley S.S., Jaffe A.J., Chang G., Schottenfeld R.S., Meyer R.E., and Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 49 (1992) 881-887
3. Altshuler H.L., Phillips P.E., and Feinhandler D.A. Alteration of ethanol self-administration by naltrexone. Life Sci 26 (1980) 679-688
4. Bouza C., Angeles M., Munoz A., and Amate J.M. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: A systematic review. Addiction 99 (2004) 811-828
5. Rubio G., Ponce G., Rodriguez-Jimenez R., Jimenez-Arriero M.A., Hoenicka J., and Palomo T. Clinical predictors of response to naltrexone in alcoholic patients: Who benefits most from treatment with naltrexone?. Alcohol Alcohol 40 (2005) 227-233
6. King A.C., Volpicelli J.R., Frazer A., and O'Brien C.P. Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology (Berl) 129 (1997) 15-22
7. Krishnan-Sarin S., Krystal J.H., Shi J., Pittman B., and O'Malley S.S. Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking. Biol Psychiatry 62 (2007) 694-697
8. Heilig M., and Egli M. Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms. Pharmacol Ther 111 (2006) 855-876
9. Bond C., LaForge K.S., Tian M., Melia D., Zhang S., Borg L., et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction. Proc Natl Acad Sci U S A 95 (1998) 9608-9613
10. Arias A., Feinn R., and Kranzler H.R. Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: A meta-analysis. Drug Alcohol Depend 83 (2006) 262-268
11. Wand G.S., McCaul M., Yang X., Reynolds J., Gotjen D., Lee S., and Ali A. The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 26 (2002) 106-114
12. Ray L.A., and Hutchison K.E. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response-A double-blind placebo-controlled study. Arch Gen Psychiatry 64 (2007) 1069-1077
13. Oslin D.W., Berrettini W., Kranzler H.R., Pettinati H., Gelernter J., Volpicelli J.R., and O'Brien C.P. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28 (2003) 1546-1552
14. Anton R.F., Oroszi G., O'Malley S., Couper D., Swift R., Pettinati H., and Goldman D. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: Results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry 65 (2008) 135-144
15. Gelernter J., Gueorguieva R., Kranzler H.R., Zhang H.P., Cramer J., Rosenheck R., and Krystal J.H. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: Results from the VA cooperative study. Alcohol Clin Exp Res 31 (2007) 555-563
16. Miller G.M., Bendor J., Tiefenbacher S., Yang H., Novak M.A., and Madras B.K. A mu-opioid receptor single nucleotide polymorphism in rhesus monkey: Association with stress response and aggression. Mol Psychiatry 9 (2004) 99-108
17. Barr C.S., Schwandt M., Lindell S.G., Chen S.A., Goldman D., Suomi S.J., et al. Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques. Arch Gen Psychiatry 64 (2007) 369-376
18. Zhang H.P., Luo X.G., Kranzler H.R., Lappalainen J., Yang B.Z., Krupitsky E., et al. Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet 15 (2006) 807-819
19. Oroszi G., Anton R.F., O'Malley S., Swift R., Pettinati H., Couper D., et al. OPRM1 Asn40Asp predicts response to naltrexone treatment: A haplotype-based approach. Alcohol Clin Exp Res 33 (2009) 383-393
20. Shabalina S.A., Zaykin D.V., Gris P., Ogurtsov A.Y., Gauthier J., Shibata K., et al. Expansion of the human mu-opioid receptor gene architecture: Novel functional variants. Hum Mol Genet 18 (2009) 1037-1051